INTANGIBLE ASSETS (Details Narrative) - USD ($)	1 Months Ended	3 Months Ended
INTANGIBLE ASSETS (Details Narrative) - USD ($)	Oct. 12, 2018	Mar. 31, 2026	Mar. 31, 2025	Dec. 31, 2025
Accumulated amortization		$ 36,199		$ 36,440
Customer [Member]
Accumulated amortization		36,199
Business combination, intangible assets acquired		336,200
Amortization expense		$ 8,290	$ 20,785
Estimated useful lives		10 years
Intellectual Property [Member]
Amortization expense		$ 295	$ 294
Accumulated amortization		6,374
Naltrexone Implant Formulation [Member] \| Australia from Trinity Compound Solutions [Member]
Patent acquired	$ 15,200
Estimated useful lives	13 years
Trademarks [Member]
Business combination, intangible assets acquired		$ 249,500